FDA – Comments Submitted to FDA on Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational Device Exemptions (IDEs)

Regulatory Comments

Comments Submitted to FDA on Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational Device Exemptions (IDEs). (Docket Number: FDA-2015-D-1777).

read the comments

Related

FDA – Comments submitted regarding Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”)

FDA – Comments submitted regarding Clinical Outcome Assessment Compendium

CIOMS – Comments submitted regarding the public consultation on the Revision of CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects